145 results
Page 4 of 8
8-K
EX-99.2
3ph2hay7upx9i96v7
13 Aug 20
Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
4:36pm
8-K/A
EX-10.6
1z6eg71iak6 c9bkw
1 Jun 20
Other Events
12:00am
8-K/A
umi 11qqdc9p61lqp
1 Jun 20
Other Events
12:00am
8-K
EX-99.2
bcx8xy
28 May 20
Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
4:41pm
8-K
EX-99.1
gx30 u0ut
28 May 20
Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
4:41pm
8-K
EX-99.1
rbzg2 7p8
24 Apr 20
Other Events
10:04am
8-K
EX-99.1
l3tuge
2 Apr 20
Departure of Directors or Certain Officers
4:32pm
DEFA14A
547 z1ou0gvrtz1y7c
28 Feb 20
Additional proxy soliciting materials
9:10am
8-K
EX-99.1
47qbsall sdngiuokky9
28 Feb 20
NewLink Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
9:08am
DEFR14A
y7s8iah jvle7ti
13 Feb 20
Revised proxy
4:37pm
DEFM14A
jx09fg6nqxb2rfczxfs
10 Feb 20
Proxy related to merger
8:30am
CORRESP
v7gsnvnk3 wv1
28 Jan 20
Correspondence with SEC
12:00am
UPLOAD
d26qcm lh3virn2
23 Jan 20
Letter from SEC
12:00am
PRER14A
ner4r8990
9 Jan 20
Preliminary revised proxy
8:02am